首页> 外国专利> HUMAN INTERFERON BETA2A AND HUMAN INTERFERON BETA2B, VECTOR CONTAINING GENE ENCODING THE INTERFERON, CELL LINE PRODUCING THE INTERFERON, AND USE OF THE INTERFERON AS MEDICAMENT

HUMAN INTERFERON BETA2A AND HUMAN INTERFERON BETA2B, VECTOR CONTAINING GENE ENCODING THE INTERFERON, CELL LINE PRODUCING THE INTERFERON, AND USE OF THE INTERFERON AS MEDICAMENT

机译:人干扰素BETA2A和人干扰素BETA2B,包含编码干扰素的基因的载体,生产干扰素的细胞系,以及使用干扰素作为药物

摘要

PURPOSE: To obtain a DNA for a recombinant vector for transforming a cell line to the cell line capable of producing human interferon useful as a medicament against growth or differentiation of cells, especially differentiation or the like of last stage cancer cells. ;CONSTITUTION: This DNA is a cDNA having a nucleotide sequence of the formula, and includes the nucleotide sequence coding for human interferon 2A having 212 amino acids. The ORF of 212 amino acids for producing 23,500 dalton protein is obtained by constructing IFN-2AE20 cDNA obtained by fusion of cDNA clone A341 and E474 hybridizing with mRNA to be translated to IFN-2, and determining the nucleotide sequence of the IFN-2 cDNA.;COPYRIGHT: (C)1995,JPO
机译:目的:获得用于重组载体的DNA,该重组载体用于将细胞系转化为能够产生人干扰素的细胞系,所述人干扰素可用作抗细胞生长或分化,尤其是晚期癌细胞的分化等的药物。 ;组成:该DNA是具有下式的核苷酸序列的cDNA,并且包括编码具有212个氨基酸的人干扰素 2 A的核苷酸序列。通过构建IFN- 2 AE20 cDNA,获得212个氨基酸的ORF,以生产23,500道尔顿的蛋白质,该cDNA通过将cDNA克隆A341和E474融合并与mRNA杂交并翻译成IFN- 2 < / Sub>,并确定IFN- 2 cDNA的核苷酸序列。版权所有:(C)1995,JPO

著录项

  • 公开/公告号JPH07265084A

    专利类型

  • 公开/公告日1995-10-17

    原文格式PDF

  • 申请/专利权人 YEDA RES & DEV CO LTD;

    申请/专利号JP19950006475

  • 发明设计人 REVEL MICHEL;ZILBERSTEIN ASHER;

    申请日1986-10-29

  • 分类号C12N15/09;C07H21/04;C12N5/10;

  • 国家 JP

  • 入库时间 2022-08-22 04:29:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号